Clostridioides Difficile Infection, An Issue of Infectious Disease Clinics of North America
Vincent B. Young
Synopsis "Clostridioides Difficile Infection, An Issue of Infectious Disease Clinics of North America"
In this issue of Infectious Disease Clinics of North America, guest editor Dr. Vincent B. Young brings his considerable expertise to the topic of Clostridioides difficile Infection. In the last decade there have been major changes in the diagnosis, epidemiology, and treatment of this important nosocomial infection. New treatments including new antibiotics and monoclonal antibodies have been developed to treat both initial episodes and recurrent CDI, and diagnostic and treatment guidelines have been created to reflect these developments. This issue addresses these changes to the clinical prevention, diagnosis, and treatment of CDI and also touches on advances in basic science that are more directly relevant to clinicians who encounter CDI in their daily professional practice. Contains 14 relevant, practice-oriented topics including infection prevention approaches for Clostridioides difficile; advances in the medical treatment of Clostridioides difficile infection; microbiome therapeutics for CDI; predicting risk and outcomes in CDI; making sense of differing guidelines for CDI; and moreProvides in-depth clinical reviews on Clostridioides difficile Infection, offering actionable insights for clinical practicePresents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews
In this issue of Infectious Disease Clinics of North America, guest editor Dr. Vincent B. Young brings his considerable expertise to the topic of Clostridioides difficile Infection. In the last decade there have been major changes in the diagnosis, epidemiology, and treatment of this important nosocomial infection. New treatments including new antibiotics and monoclonal antibodies have been developed to treat both initial episodes and recurrent CDI, and diagnostic and treatment guidelines have been created to reflect these developments. This issue addresses these changes to the clinical prevention, diagnosis, and treatment of CDI and also touches on advances in basic science that are more directly relevant to clinicians who encounter CDI in their daily professional practice.Contains 14 relevant, practice-oriented topics including infection prevention approaches for Clostridioides difficile; advances in the medical treatment of Clostridioides difficile infection; microbiome therapeutics for CDI; predicting risk and outcomes in CDI; making sense of differing guidelines for CDI; and moreProvides in-depth clinical reviews on Clostridioides difficile Infection, offering actionable insights for clinical practicePresents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews
